{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T13:10:09Z","timestamp":1746709809524,"version":"3.40.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,8]]},"DOI":"10.7759\/cureus.83723","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T12:34:52Z","timestamp":1746707692000},"source":"Crossref","is-referenced-by-count":0,"title":["A Comprehensive Approach to Differentiating Systemic Lupus Erythematosus From Other Autoimmune Diseases Presenting With Optic Neuritis"],"prefix":"10.7759","author":[{"given":"Jason","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Alrifai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore D","family":"DeSimone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro M","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Traisak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa","family":"Karpoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Feinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala","family":"Eid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph D","family":"DeSimone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-043021-032611","article-title":"Systemic lupus erythematosus: new diagnostic and therapeutic approaches","volume":"74","author":"Lazar S","year":"2023","unstructured":"Lazar S, Kahlenberg JM. Systemic lupus erythematosus: new diagnostic and therapeutic approaches. Annu Rev Med. 2023, 74:339-52. 10.1146\/annurev-med-043021-032611","journal-title":"Annu Rev Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2022-222276","article-title":"Rising incidence and prevalence of systemic lupus erythematosus: a population-based study over four decades","volume":"81","author":"Duarte-Garc\u00eda A","year":"2022","unstructured":"Duarte-Garc\u00eda A, Hocaoglu M, Valenzuela-Almada M, et al.. Rising incidence and prevalence of systemic lupus erythematosus: a population-based study over four decades. Ann Rheum Dis. 2022, 81:1260-6. 10.1136\/annrheumdis-2022-222276","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223035","article-title":"Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study","volume":"82","author":"Tian J","year":"2023","unstructured":"Tian J, Zhang D, Yao X, Huang Y, Lu Q. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis. 2023, 82:351-6. 10.1136\/ard-2022-223035","journal-title":"Ann Rheum Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320983445","article-title":"Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: cross sectional analysis of the LuLa cohort","volume":"30","author":"Kernder A","year":"2021","unstructured":"Kernder A, Richter JG, Fischer-Betz R, et al.. Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: cross sectional analysis of the LuLa cohort. Lupus. 2021, 30:431-8. 10.1177\/0961203320983445","journal-title":"Lupus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00161","article-title":"Systemic lupus erythematosus in primary care: an update and practical messages for the general practitioner","volume":"5","author":"Gergianaki I","year":"2018","unstructured":"Gergianaki I, Bertsias G. Systemic lupus erythematosus in primary care: an update and practical messages for the general practitioner. Front Med (Lausanne). 2018, 5:161. 10.3389\/fmed.2018.00161","journal-title":"Front Med (Lausanne)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315603142","article-title":"Optic nerve involvement in childhood onset systemic lupus erythematosus: three cases and a review of the literature","volume":"25","author":"Suri D","year":"2016","unstructured":"Suri D, Abujam B, Gupta A, et al.. Optic nerve involvement in childhood onset systemic lupus erythematosus: three cases and a review of the literature. Lupus. 2016, 25:93-6. 10.1177\/0961203315603142","journal-title":"Lupus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4806","article-title":"Systemic lupus erythematosus presenting as optic neuropathy: a case report","volume":"11","author":"Zahid S","year":"2019","unstructured":"Zahid S, Iqbal M. Systemic lupus erythematosus presenting as optic neuropathy: a case report. Cureus. 2019, 11:e4806. 10.7759\/cureus.4806","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.21608\/ejhm.2020.92542","article-title":"Optic disc swelling as the first presentation of systemic lupus erythematosus: a case report","volume":"80","author":"Abdulqader A","year":"2020","unstructured":"Abdulqader A. Optic disc swelling as the first presentation of systemic lupus erythematosus: a case report. Egyptian J Hosp Med. 2020, 80:633-7.","journal-title":"Egyptian J Hosp Med"},{"key":"ref9","article-title":"Optic neuritis: pathophysiology, clinical features, and diagnosis","author":"Osborne B","year":"2021","unstructured":"Osborne B. Optic neuritis: pathophysiology, clinical features, and diagnosis. UpToDate. Wilterdink JL (ed): Wolters Kluwer, Philadelphia, PA; 2021."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.3502","article-title":"Trends in optic neuritis incidence and prevalence in the UK and association with systemic and neurologic disease","volume":"77","author":"Braithwaite T","year":"2020","unstructured":"Braithwaite T, Subramanian A, Petzold A, et al.. Trends in optic neuritis incidence and prevalence in the UK and association with systemic and neurologic disease. JAMA Neurol. 2020, 77:1514-23. 10.1001\/jamaneurol.2020.3502","journal-title":"JAMA Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_3415_20","article-title":"Approach to optic neuritis: an update","volume":"69","author":"Phuljhele S","year":"2021","unstructured":"Phuljhele S, Kedar S, Saxena R. Approach to optic neuritis: an update. Indian J Ophthalmol. 2021, 69:2266-76. 10.4103\/ijo.IJO_3415_20","journal-title":"Indian J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-020-00247-9","article-title":"Vision loss from atypical optic neuritis: patient and physician perspectives","volume":"9","author":"Braithwaite T","year":"2020","unstructured":"Braithwaite T, Wiegerinck N, Petzold A, Denniston A. Vision loss from atypical optic neuritis: patient and physician perspectives. Ophthalmol Ther. 2020, 9:215-20. 10.1007\/s40123-020-00247-9","journal-title":"Ophthalmol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00187-9","article-title":"Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment","volume":"22","author":"Bennett JL","year":"2023","unstructured":"Bennett JL, Costello F, Chen JJ, Petzold A, Biousse V, Newman NJ, Galetta SL. Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment. Lancet Neurol. 2023, 22:89-100. 10.1016\/S1474-4422(22)00187-9","journal-title":"Lancet Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/2055217318768330","article-title":"Coexistence of systemic lupus erythematosus and multiple sclerosis. A case report and literature review","volume":"4","author":"J\u00e1come S\u00e1nchez EC","year":"2018","unstructured":"J\u00e1come S\u00e1nchez EC, Garc\u00eda Castillo MA, Gonz\u00e1lez VP, Guill\u00e9n L\u00f3pez F, Correa D\u00edaz EP. Coexistence of systemic lupus erythematosus and multiple sclerosis. A case report and literature review. Mult Scler J Exp Transl Clin. 2018, 4:2055217318768330. 10.1177\/2055217318768330","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-021-01000-2","article-title":"Neuromyelitis optica spectrum disorders (NMOSD) and connective tissue disease (CTD): an update for the rheumatologist","volume":"23","author":"Cruz RA","year":"2021","unstructured":"Cruz RA, Chaudhary S, Guevara M, Meltzer E. Neuromyelitis optica spectrum disorders (NMOSD) and connective tissue disease (CTD): an update for the rheumatologist. Curr Rheumatol Rep. 2021, 23:33. 10.1007\/s11926-021-01000-2","journal-title":"Curr Rheumatol Rep"},{"key":"ref16","unstructured":"Cleveland Clinic. Optic neuritis. (2019). Accessed. April 8, 2025: https:\/\/my.clevelandclinic.org\/health\/diseases\/14256-optic-neuritis."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2147\/EB.S69173","article-title":"Infectious optic neuropathies: a clinical update","volume":"7","author":"Kahloun R","year":"2015","unstructured":"Kahloun R, Abroug N, Ksiaa I, Mahmoud A, Zeghidi H, Zaouali S, Khairallah M. Infectious optic neuropathies: a clinical update. Eye Brain. 2015, 7:59-81. 10.2147\/EB.S69173","journal-title":"Eye Brain"},{"key":"ref18","unstructured":"National Heart, Lung, and Blood Institute. Study quality assessment tools . (2021). Accessed. April 8, 2025: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320905668","article-title":"Clinical features of transverse myelitis associated with systemic lupus erythematosus","volume":"29","author":"Zhang S","year":"2020","unstructured":"Zhang S, Wang Z, Zhao J, et al.. Clinical features of transverse myelitis associated with systemic lupus erythematosus. Lupus. 2020, 29:389-97. 10.1177\/0961203320905668","journal-title":"Lupus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2013.07.010","article-title":"Demyelinating disease in SLE: is it multiple sclerosis or lupus?","volume":"27","author":"Magro Checa C","year":"2013","unstructured":"Magro Checa C, Cohen D, Bollen EL, van Buchem MA, Huizinga TW, Steup-Beekman GM. Demyelinating disease in SLE: is it multiple sclerosis or lupus?. Best Pract Res Clin Rheumatol. 2013, 27:405-24. 10.1016\/j.berh.2013.07.010","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.01.027","article-title":"Optic neuritis with positive HLA-B27: characteristic phenotype in the Chinese population","volume":"362","author":"Zhao S","year":"2016","unstructured":"Zhao S, Zhou H, Peng X, et al.. Optic neuritis with positive HLA-B27: characteristic phenotype in the Chinese population. J Neurol Sci. 2016, 362:100-5. 10.1016\/j.jns.2016.01.027","journal-title":"J Neurol Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2014.11.014","article-title":"Longitudinally extensive transverse myelitis in systemic lupus erythematosus: case report and review of the literature","volume":"129","author":"Nardone R","year":"2015","unstructured":"Nardone R, Fitzgerald RT, Bailey A, Zuccoli G. Longitudinally extensive transverse myelitis in systemic lupus erythematosus: case report and review of the literature. Clin Neurol Neurosurg. 2015, 129:57-61. 10.1016\/j.clineuro.2014.11.014","journal-title":"Clin Neurol Neurosurg"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055843","article-title":"Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients","volume":"8","author":"Kampylafka EI","year":"2013","unstructured":"Kampylafka EI, Alexopoulos H, Kosmidis ML, et al.. Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients. PLoS One. 2013, 8:e55843. 10.1371\/journal.pone.0055843","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102425","article-title":"Epidemiology and comorbidities of adult multiple sclerosis and neuromyelitis optica in Taiwan, 2001-2015","volume":"45","author":"Fang CW","year":"2020","unstructured":"Fang CW, Wang HP, Chen HM, Lin JW, Lin WS. Epidemiology and comorbidities of adult multiple sclerosis and neuromyelitis optica in Taiwan, 2001-2015. Mult Scler Relat Disord. 2020, 45:102425. 10.1016\/j.msard.2020.102425","journal-title":"Mult Scler Relat Disord"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2022.107381","article-title":"Clinical and diagnostic spectrum of optic neuritis: a single-center retrospective study of disorders associated with multiple sclerosis, anti-aquaporin-4 and anti-myelin oligodendrocyte glycoprotein antibodies","volume":"221","author":"Siegel DR","year":"2022","unstructured":"Siegel DR, Van Harn M, Taguchi M, Bansal P, Cerghet M, Memon AB. Clinical and diagnostic spectrum of optic neuritis: a single-center retrospective study of disorders associated with multiple sclerosis, anti-aquaporin-4 and anti-myelin oligodendrocyte glycoprotein antibodies. Clin Neurol Neurosurg. 2022, 221:107381. 10.1016\/j.clineuro.2022.107381","journal-title":"Clin Neurol Neurosurg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319877255","article-title":"Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder and systemic autoimmune diseases overlap syndrome: a single-center experience","volume":"28","author":"Mart\u00edn-Nares E","year":"2019","unstructured":"Mart\u00edn-Nares E, Hernandez-Molina G, Fragoso-Loyo H. Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder and systemic autoimmune diseases overlap syndrome: a single-center experience. Lupus. 2019, 28:1302-11. 10.1177\/0961203319877255","journal-title":"Lupus"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2012.05.017","article-title":"Clinical and magnetic resonance imaging features of multiple sclerosis with autoreactive antibodies in Ishikawa Prefecture, Japan","volume":"250","author":"Takahashi K","year":"2012","unstructured":"Takahashi K, Tanaka K. Clinical and magnetic resonance imaging features of multiple sclerosis with autoreactive antibodies in Ishikawa Prefecture, Japan. J Neuroimmunol. 2012, 250:111-4. 10.1016\/j.jneuroim.2012.05.017","journal-title":"J Neuroimmunol"},{"key":"ref28","article-title":"Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO)","volume":"60","author":"Asgari N","year":"2013","unstructured":"Asgari N. Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO). Dan Med J. 2013, 60:B4730.","journal-title":"Dan Med J"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.12.028","article-title":"Neuromyelitis optica spectrum disorder presenting with concurrent autoimmune diseases","volume":"28","author":"Bibic VC","year":"2019","unstructured":"Bibic VC, Brust TB, Burton JM. Neuromyelitis optica spectrum disorder presenting with concurrent autoimmune diseases. Mult Scler Relat Disord. 2019, 28:125-8. 10.1016\/j.msard.2018.12.028","journal-title":"Mult Scler Relat Disord"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320978514","article-title":"MOG-IgG-associated disorder and systemic lupus erythematosus disease: systematic review","volume":"30","author":"Caroline Breis L","year":"2021","unstructured":"Caroline Breis L, Ant\u00f4nio Machado Schlindwein M, Pastor Bandeira I, et al.. MOG-IgG-associated disorder and systemic lupus erythematosus disease: systematic review. Lupus. 2021, 30:385-92. 10.1177\/0961203320978514","journal-title":"Lupus"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2016.06.011","article-title":"Longitudinally extensive transverse myelitis: a retrospective analysis of sixty-four patients at tertiary care center of North-West India","volume":"148","author":"Jain RS","year":"2016","unstructured":"Jain RS, Kumar S, Mathur T, Tejwani S. Longitudinally extensive transverse myelitis: a retrospective analysis of sixty-four patients at tertiary care center of North-West India. Clin Neurol Neurosurg. 2016, 148:5-12. 10.1016\/j.clineuro.2016.06.011","journal-title":"Clin Neurol Neurosurg"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319888692","article-title":"Neuromyelitis optica spectrum disorder and systemic lupus erythematosus","volume":"28","author":"Thabah MM","year":"2019","unstructured":"Thabah MM, D S, Pranov R, Moulitej MM, Ramesh A, Kadhiravan T. Neuromyelitis optica spectrum disorder and systemic lupus erythematosus. Lupus. 2019, 28:1722-6. 10.1177\/0961203319888692","journal-title":"Lupus"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2014.11.020","article-title":"Presence of anti-Ro\/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder","volume":"348","author":"Park JH","year":"2015","unstructured":"Park JH, Hwang J, Min JH, Kim BJ, Kang ES, Lee KH. Presence of anti-Ro\/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder. J Neurol Sci. 2015, 348:132-5. 10.1016\/j.jns.2014.11.020","journal-title":"J Neurol Sci"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-016-2523-z","article-title":"Intractable pruritus in neuromyelitis optica","volume":"37","author":"Xiao L","year":"2016","unstructured":"Xiao L, Qiu W, Lu Z, Li R, Hu X. Intractable pruritus in neuromyelitis optica. Neurol Sci. 2016, 37:949-54. 10.1007\/s10072-016-2523-z","journal-title":"Neurol Sci"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s41747-020-00186-x","article-title":"Ultra-high-field 7-T MRI in multiple sclerosis and other demyelinating diseases: from pathology to clinical practice","volume":"4","author":"Bruschi N","year":"2020","unstructured":"Bruschi N, Boffa G, Inglese M. Ultra-high-field 7-T MRI in multiple sclerosis and other demyelinating diseases: from pathology to clinical practice. Eur Radiol Exp. 2020, 4:59. 10.1186\/s41747-020-00186-x","journal-title":"Eur Radiol Exp"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182648bc8","article-title":"Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis","volume":"79","author":"Sinnecker T","year":"2012","unstructured":"Sinnecker T, D\u00f6rr J, Pfueller CF, et al.. Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology. 2012, 79:708-14. 10.1212\/WNL.0b013e3182648bc8","journal-title":"Neurology"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1159\/000369616","article-title":"Neuromyelitis optica with cutaneous findings: case report and review of the literature","volume":"230","author":"Martin C","year":"2015","unstructured":"Martin C, Maurer T, Mutizwa MM. Neuromyelitis optica with cutaneous findings: case report and review of the literature. Dermatology. 2015, 230:289-92. 10.1159\/000369616","journal-title":"Dermatology"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.577045","article-title":"The GTF2I rs117026326 polymorphism is associated with neuromyelitis optica spectrum disorder but not with multiple sclerosis in a Northern Han Chinese population","volume":"337","author":"Liang H","year":"2019","unstructured":"Liang H, Gao W, Liu X, et al.. The GTF2I rs117026326 polymorphism is associated with neuromyelitis optica spectrum disorder but not with multiple sclerosis in a Northern Han Chinese population. J Neuroimmunol. 2019, 337:577045. 10.1016\/j.jneuroim.2019.577045","journal-title":"J Neuroimmunol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02725","article-title":"Low-density granulocytes are a novel immunopathological feature in both multiple sclerosis and neuromyelitis optica spectrum disorder","volume":"10","author":"Ostendorf L","year":"2019","unstructured":"Ostendorf L, Mothes R, van Koppen S, et al.. Low-density granulocytes are a novel immunopathological feature in both multiple sclerosis and neuromyelitis optica spectrum disorder. Front Immunol. 2019, 10:2725. 10.3389\/fimmu.2019.02725","journal-title":"Front Immunol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319855125","article-title":"Aquaporin-4 IgG antibody-related disorders in patients with juvenile systemic lupus erythematosus","volume":"28","author":"Moraitis E","year":"2019","unstructured":"Moraitis E, Stathopoulos Y, Hong Y, et al.. Aquaporin-4 IgG antibody-related disorders in patients with juvenile systemic lupus erythematosus. Lupus. 2019, 28:1243-9. 10.1177\/0961203319855125","journal-title":"Lupus"},{"key":"ref41","article-title":"Antinucleosome antibodies and primary antiphospholipid syndrome: an observational study","volume":"52","author":"de Souza AW","year":"2012","unstructured":"de Souza AW, Keusseyan SP, da Silva NP, Sato EI, Andrade LE. Antinucleosome antibodies and primary antiphospholipid syndrome: an observational study. Rev Bras Reumatol. 2012, 52:357-65.","journal-title":"Rev Bras Reumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/360934-a-comprehensive-approach-to-differentiating-systemic-lupus-erythematosus-from-other-autoimmune-diseases-presenting-with-optic-neuritis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T12:34:55Z","timestamp":1746707695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/360934-a-comprehensive-approach-to-differentiating-systemic-lupus-erythematosus-from-other-autoimmune-diseases-presenting-with-optic-neuritis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":41,"URL":"https:\/\/doi.org\/10.7759\/cureus.83723","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,8]]}}}